 |
Re188 P2045 somatostatin peptide analogue |
|---|---|
| Trade Name | |
| Orphan Indication | Pancreatic cancer |
| USA Market Approval | USA |
| USA Designation Date | 2014-06-19 00:00:00 |
| Sponsor | Andarix Pharmaceuticals, Inc.;141 Powderhouse Blvd, Suite 1;Somerville, Massachusetts, 02144 |
